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The aim of this paper was to determine in 32 patients from 4 diﬀerent Mexican hospitals the frequency of opportunistic bacteria
in the 2010 to 2011 time period. The patients were divided in 4 groups. Group 1 included 21 HIV positive patients with acute
respiratory syndrome. Four HIV positive patients with tuberculosis symptoms were included in Group 2; two patients with
tuberculosis symptoms and one asymptomatic person formed Group 3. Reference Group 4 included 4 patients from whom 4
strains of Mycobacterium spp. had been reported. The strains were isolated and identiﬁed by 16S rRNA gene ampliﬁcation, API
20E and 50CH, biochemical test, and antibiotic sensitivity. The strains found were 10 Pantoea agglomerans,6Mycobacterium spp.,
6 Pseudomonas spp. and 10 strains of normal ﬂoral species: Thermoactinomycetes bacterium (1), Enterococcus faecium (2), Bacillus
licheniformis (1), Lactobacillus rhamnosus (2), Streptococcus oralis (2), Streptococcus anginosus (1), and Enterobacter hormaechei(1).
1.Introduction
Immunodeﬁciency is the main conditioning factor for bac-
terial infection susceptibility; therefore, immunodeﬁcient
patients frequently present several aggregated infections [1].
Since the eighties there has been an increase in opportunistic
microorganisms in addition to the human immunodeﬁ-
ciency virus (HIV positive) [2] .S o m ed i s e a s e ss u c ha st u b e r -
culosis (TB) are related to HIV positive infection but the
symptoms and signs are nonspeciﬁc and it is diﬃcult to
distinguish TB from other opportunistic infections. The pa-
tient may have acute symptoms for a few hours or days or
fever and nonspeciﬁc systemic symptoms for several days
or weeks similar to bacterial infection (or weight loss) [3,
4].
It has been established that worldwide 60 million people
have active TB and 2-3 million die yearly due to Mycobac-
terium tuberculosis. The complex diagnosis of respiratory
symptoms leads to believe that other opportunistic bacteria
such as P. agglomerans are involved in immunodeﬁcient pa-
tients [3]. P. agglomerans is a Gram negative bacillus of the
Enterobacteriaceae family. It is ubiquitous and found in
humans, animals, and plants [5, 6], soil, and water, and it
is an important microorganism from the medical point of
view[7]. It is often opportunistic and requires an immunod-
e ﬁ c i e n th o s tf o ri t sg r o w t h[ 8].
This bacterium causes infection and is frequently associ-
ated to other conventional pathogens [9]. In the diagnosis of
infectious diseases and identiﬁcation of the causal agent, the
molecular biology methods are useful. The comparative seq-2 The Scientiﬁc World Journal
uencing of the 16s rRNA gene conﬁrms the presence of op-
portunistic microorganisms in immnodeﬁcient patients
[10].
The objective of this research was to identify the predo-
minant bacterial species in HIV positive and other immun-
odeﬁcient patients with respiratory symptoms and with or
without a TB diagnosis.
2.MaterialsandMethods
2.1. Patients. The study included 32 patients from four hos-
pitals in the State of Mexico, during the years 2010-2011, and
were divided into four groups.
Group 1: HIV Positive Patients with Acute Respiratory Syn-
drome. Twenty-oneHIVpositivepatientswithacuterespira-
t o r ys y n d r o m e ,1 6m a l e sa n d5f e m a l e s ,a g e d3 1t o5 4y e a r s ,
came from the “Acquired Inmunedeﬁciency Syndrome
(AIDS)” clinic of a main hospital. They presented 41 to 958
CD4 values and <40–110 viral load. They also presented res-
piratory symptoms, coughing, expectoration, and a 3–20kg
weight loss suggestive of TB. No laboratory tests to conﬁrm
the diagnoses were carried out until this study began but the
patients received antiretroviral treatment.
Group 2: HIV Positive Patients with TB Syndrome. Four HIV
positive patients with TB syndrome, 3 males and one female
31–37 years old, with 288–576 CD4 values and no detectable
viral load were admitted to a specialized AIDS and sexual
transmitted disease hospital, with a diagnoses suggestive of
T B( c o u g h ,e x p e c t o r a t i o n ,f e v e r ,a n da5 – 1 3k gw e i g h tl o s s ) .
The diagnosis was conﬁrmed by bacilloscopy and the pa-
tients received a doTBal shortened strictly supervised tuber-
culosis treatment (TAES) rifampicin, isoniazid, 3 pyrazina-
mide, and ethambutol chloride, for six months.
Group 3: Patients with a TB Syndrome. Two patients with a
TB syndrome, a 32-years-old male and a 39-year-old female,
from an AIDS and sexually transmitted diseases clinic, pre-
sented cough, expectoration, fever, and 5 and 10kg weight
loss, respectively, and were diagnosed with TB after positive
bacilloscopy. They received a doTBal shortened strictly sup-
ervised treatment (TAES) (rifampicin, isoniazid, pyrazina-
mide, and ethambutol chloride for six months. A sputum
sample was obtained from a 30-year-old male companion
without symptoms or diagnosis but with laboratory diag-
nostic tests. He was considered as an asymptomatic high-risk
patient.
Group 4: Reference Group. Four patients were located from
a retrospective study (2007–2010) of 186 clinical ﬁles of a
specialized hospital to detect the number of patients with TB
and the most common Mycobacterium strain in the State of
Mexico. This hospital provided four bacterial strains, already
isolated, from the four patients and identiﬁed as Mycobac-
terium spp. by means of the Polymerase Chain Reaction
(PCR) technique. The diﬀerence between Group 3 and
Group 4 is that strains of Group 3 were isolated by us and
strains of Group 4 were provided already isolated by the
hospital’s laboratory staﬀ and patients were not available.
2.2. Specimen Procurement and Processing. In accordance
with the guideline for tuberculosis bacteriological diagnoses
(MDBT) [11, 12], the 28 patients from Groups 1–3 were
interviewed while fasting and asked for a sputum sample for
3 consecutive days. The specimens were collected in sterile
ﬂasks and processed at the Medical and Environmental
Microbiology Laboratory of the Faculty of Medicine at the
Autonomous University of the State of Mexico, Mexico, and
wereanalyzedinaccordancewiththeguidelineforTBbacter-
iological diagnoses. The specimens were submitted to a dig-
estive liquefaction and decontamination process with alka-
line N-acethyl-L-cysteine in order to eliminate bacteria that
interfere with Mycobacterium and to liquefy tissue, mucus,
and other organic materials [11, 12].
2.3. Culturing and Isolation. Decontaminated samples were
put into in commercial Lowenstein-Jensen (LJ) (BD BBL
0196675) medium, incubated at 37◦C for 3-4 weeks, and re-
vised every 7 days. The cultured bacteria were transferred to
PetriplatescontainingMiddlebrook7H10Agar(Difco,USA)
glycerol and OADC enrichment culture medium and incu-
bated at 37◦C[ 11, 12]. The 32 strains were cultured in the
Middlebrook liquid medium to obtain biomass for DNA
extraction.
Twenty-eight strains from the patients of Groups 1, 2,
and 3 were obtained considering the colony morphology:
size, color, surface, and consistency, and 4 strains from the
patients in the reference group were acquired from the IMSS
MedicalCenter“SigloXXl”TuberculosisService.Thechosen
bacteria were smeared, the slides were stained with Ziehl-
Neelsen for acid-alcohol resistant bacilli (BAAR) [5, 13], and
a CME Microscope 1349521X (Leica, USA) was used.
2.4. Genetic Characterization. For total DNA extraction the
Wizard Genomic Puriﬁcation DNA Kit (Promega A1120)
(Isolation of genomic DNA from Gram positive and Gram
negative bacteria) was used. For PCR ampliﬁcations and seq-
uencing, A 1300–1500bp fragment of the 16S rRNA gene
wasampliﬁedwithprimers8F(5 -AGAGTTTGATCATGG
CTC AG-3 ) and 1492R (5 -TAC GGT TAC CTT GTT ACG
ACT T-3 ). After 30 cycles of denaturation at 94◦Cf o r6 0s ,
primer annealing at 55◦Cf o r2 0s ,a n dp r i m e re x t e n s i o na t
72◦C for 60s, followed by postampliﬁcation extension at
72◦C for 10min, ampliﬁcation was seen in (1%) agarose gel
electrophoresisat90voltsfor30min.Theampliﬁedproducts
were sequenced for Bagdye terminator to Macrogen USA.
Sequences corresponding to both regions were assembled
and edited using BioEdit software version 7.0.5 [14]a n da
consensus sequence of each isolate was created. Since the
Basic Local Alignment Search Tool (BLASTN) from the
NCBI ﬁnds regions of local similarity between sequences
withsigniﬁcantalignments,consensussequencesofeachiso-
late obtained for 16S rDNA partial sequence were submitted
to BLASTN 2.2.25 [15].
2.5. Predominant Strains. The identiﬁed predominant group
of strains were subjected to phylogenetic and biochemical
characterization and to antibiotic sensibility studies.The Scientiﬁc World Journal 3
2.6. Phylogeny. All consensus sequences were compiled into
a single ﬁle (Fasta format) for evolutionary analyses and then
aligned with the proﬁle mode of Clustal W 1.8.1 [16] includ-
ed in Mega 4.0.2 software [17]. Phylogeny reconstruction
analysis was performed with a Maximum Parsimony method
on the P. agglomerans dataset. This analysis was performed
using search options Close Neighbor Interchange (CNI)
search (level = 1), with an initial tree by random addition
(10 reps); gap/missing data were considered as a complete
deletion.
2.7. Biochemical Characterization. For the biochemical char-
acterization each colony was identiﬁed using the API 20E
(Biom´ erieux B-20100) and API 50CH proﬁle index (Bio-
m´ erieux B-50300). The systems were incubated at 35◦Ca n d
all reactions were read after 20 to 24h. Results of aﬃrmative
or negative tests were recorded and interpreted according to
the manufacturer’s directions [18].
2.8. Antibiotic Sensitivity. For antibiotic sensitivity the
strainswereculturedinMueller-HintonAgar(MH)(Bioxon,
U.S.A); antimicrobial susceptibility was determined with the
disk diﬀusion method accordingly to the National Commit-
tee for Clinical Laboratory Standards (NCCLS) [19]. The
bacteria were classiﬁed as resistant (R), intermediate (I), and
susceptible (S) to a particular antimicrobial agent. The anti-
biotics used were amikacin, ampicillin, carbenicillin, cepha-
lothin, cefotaxime, ceftriaxone, chloramphenicol, gentami-
cin,netilmicin,nitrofurantoin,peﬂoxacin,andtrimetoprim-
sulfametoxazol. Petri dishes containing the antibiotic disks
wereinoculatedandincubatedat35◦Cfor24h.Resistanceor
susceptibility to any of the antibiotics was determined from
the halo diameter and data found in tables [19].
3. Results
The demographic characteristics of the patients, the CD4
values, and viral load are shown in Table 1.
3.1. Bacilloscopy. Of the 28 sputum specimens, 12 were
BAAR positive: ﬁve strains from Group 1 patients, four
strains from Group 2, and three strains from Group 3 pa-
tients. All the isolates showed good growth in the two culture
media (LJ and Middlebrook 7H10). The acid-fast smear
microscopy results (>90%) were given to the health care pro-
vider within 24 hours of receipt of all specimens.
3.2. Macroscopic and Microscopic Morphology of the Bacteria.
The macroscopic and microscopic morphology of the bac-
teria allowed grouping in four categories. Category A inclu-
ded small size, yellow, round, and creamy like colonies. Ten
strains were short bacilli, with round ends, Gram negative,
and no BAAR. Category B was small size, dark yellow, round,
and wrinkled colonies. In 6 strains the bacilli were elongated,
Grampositive,andacid-alcoholresistant.CategoryCinclud-
ed medium size, cream and yellow color, round, and creamy
colonies.Sixstrainsshowedstraightorslightlycurvedbacilli,
Gram negative, and no BAAR. Category D included a variety
of small to medium size, yellow and cream color, smooth,
hard, and creamy colonies. Ten strains were of Gram positive
diplococci and Gram positive bacilli, no BAAR. The acid-fast
smear microscopy results (>90%) were given to the health
care provider within 24 hours of receipt of all specimens.
3.3. Identiﬁcation. With the comparative analysis of the ob-
tained sequences deposited in Gen Bank, the principal spec-
ies were identiﬁed: ten strains were identiﬁed as P. agglomer-
ans corresponding to Category A; six strains corresponding
to Category B were identiﬁed as Mycobacterium spp. (2M.
tuberculosis y4M. parascrofulaceum); six strains correspond-
ingtoCategoryCwerePseudomonasspp.(1strainwasP. kor-
eensis, 4 strains were P. azelaica, and one was P. aerogenes); in
the D category 10 strains of the normal ﬂora were identiﬁed
as species Thermoactinomycetes bacterium (1), Enterococcus
faecium (2), Bacillus licheniformis (1), Lactobacillus rhamno-
sus (2),S t r e p t o c o c c u so r a l i s(2),S t r e p t o c o c c u sa n g i n o s u s(1),
and Enterobacter hormaechei (1). The distribution and per-
centage of the strains in their Categories are shown in
Table 2.
3.4. Phylogeny. The analysis of the sequencing of fragment
1367bpwithoutgapsfrom16SrRNAgenewascarriedoutby
comparison with ﬁve species of the genus Enterobacter and
three species of the genus Pantoea, and the sequence of
Nocardia brasiliensis was used to form the roots of the tree.
The ten analysed strains were grouped with the P. agglomer-
ans sequence with 91% bootstrap value (Figure 1).
3.5. Biochemical Characterization by API 20E and API 50CH
Test Strips. Since P. agglomerans predominated (31.25%), it
underwent phylogeny studies and antibiotic sensibility
assays. The ten P. agglomerans strains were biochemical
characterized by API 20E and API 50CH test strips. All had
the same proﬁle with both systems indicating that are aero-
bic bacteria and ferment: B-galactose, lactose, saccharose,
ornithine, glucose, arabinose, arginine, mannitol, inositol,
sorbitol, rhamnose, melibiose, and amygdaline. Voges Pro-
skauerwaspositiveand,therefore,producedbuthyenlglicolic
fermentation.Theyarecitratepositiveandindolnegative,do
not produce sulphydric acid or urease, do not produce de-
samination of tryptophan substrate or urease, and do not
catabolize lysine and the gelatinase test was negative.
3.6. Antimicrobial Susceptibility. Most of the P. agglomerans
were resistant to carbeniillin, ceftriaxone, chloramphenicol,
gentamycin, netilmicin, nitrofurantoin, and peﬂoxacin.
Some strains were resistant to amikacin, ampicillin, and cto-
yoxin (Table 3).
4. Discussion
The symptoms of the included patients are similar to those
produced by Mycobacterium spp. Nevertheless, the presence
of two or more causes for pulmonary disease is also charac-
teristic of HIV positive patients who frequently present with
bacterial infections, an important cause for high morbility4 The Scientiﬁc World Journal
Table 1: Demographic characteristics of the patients, CD4 values and viral load.
Patients Code Male/female Age Weight loss
(kg) Values of CD4 Viral load
Group 1. HIV positive patients with acute respiratory syndrome
(1) E1 M 51 3 47 77
(2) NR1b M 39 20 850 <40
(3) E2 F 39 6 395 60
(4) E4 M 45 6 958 <40
(5) NR5 F 44 6 837 <40
(6) NR6 M 39 5 377 <40
(7) NR7 M 43 6 ND ND
(8) NR8 M 36 6 329 <40
(9) NR9 M 35 10 267 <40
(10) NR10 M 40 7 41 <40
(11) E6 M 31 10 ND ND
(12) NR14 M 45 8 316 <40
(13) NR15 M 31 4 579 <40
(14) NR17 M 37 7 814 82
(15) NR18 F 54 Without loss ND ND
(16) NR19 F 41 15 809 <40
(17) NR21 M 30 10 492 111
(18) NR22 M 27 3 474 66
(19) NR23 F 35 16 662 <40
(20) NR24 M 32 18 ND ND
(21) NR25 M 31 3 623 <40
Group 2. HIV positive patients with TB syndrome
(1) E9 M 35 10 288 Indetectable
(2) NR41 M 31 5 345 Indetectable
(3) NR42 F 26 Without loss 576 Indetectable
(4) NR43 M 37 13 438 Indetectable
Group 3. Patients with TB syndrome
(1) NR36 M 32 5 No No
(2) NR31 F 39 10 No No
(3) NR37 M 30 Without loss No No
Group 4. Reference group
(1) NR51 M 51 Without loss No No
(2) NR52 F 51 Without loss No No
(3) NR53 M 81 2 No No
(4) NR54 F 85 5 No No
ND: No determined; NO: no CD4 values/no viral load determined.
and mortality. Some researchers have indicated that this sit-
uation occurs in 39% of the patients [20] and others have
established that nosocomial infections increase in 5% a fatal
risk [21].
Garc´ ıaetal.(2003)reportedthat100%ofthepatientsad-
mitted in a hospital present with pulmonary diseases mostly
due to opportunistic infections (98.7%), and in HIV positive
patients, the 3 principal causes were, TB, bacterial pneumo-
nia and other no speciﬁed infectious neumonia [22].
The results of this investigation indicate that not all res-
piratory syndrome in immunodeﬁcient patients is due to
TB. The patients studied presented with productive coughThe Scientiﬁc World Journal 5
Table 2: Sequenced identiﬁed bacteria and the similarity percentage calculated with the BLASTN program.
Patients Code BLASTN program Morphology
group Similarity percentage
Group 1. HIV positive patients with acute respiratory syndrome
(1) E1 Thermoactinomycetes bacterium Category D 99
(2) NR1b Pantoea agglomerans Category A 100
(3) E2 Enterococcus faecium Category D 100
(4) E4 Pantoea agglomerans Category A 100
(5) NR5 Pantoea agglomerans Category A 99
(6) NR6 Bacillus licheniformis Category B 99
(7) NR7 Lactobacillus rhamnosus Category D 99
(8) NR8 Streptococcus oralis Category D 99
(9) NR9 Pantoea agglomerans Category A 99
(10) NR10 Streptococcus anginosus Category D 99
(11) E6 Lactobacillus rhamnosus Category D 97
(12) NR14 Enterobacter hormaechei Category D 99
(13) NR15 Pantoea agglomerans Category A 99
(14) NR17 Pantoea agglomerans Category A 100
(15) NR18 Enterococcus faecium Category D 97
(16) NR19 Pseudomonas koreensis Category C 99
(17) NR21 Pseudomonas azelaica Category C 99
(18) NR22 Pseudomonas azelaica Category C 99
(19) NR23 Pseudomonas azelaica Category C 99
(20) NR24 Pantoea agglomerans Category A 99
(21) NR25 Streptococcus oralis Category E 99
Group 2. HIV positive patients with TB syndrome
(1) E9 Pseudomonas aeruginosa Category C 99
(2) NR41 Pseudomonas azelaica Category C 99
(3) NR42 Pantoea agglomerans Category A 99
(4) NR43 Pantoea agglomerans Category A 100
Group 3. Patients with a TB syndrome
(1) NR36 Mycobacterium tuberculosis Category B 100
(2) NR31 Pantoea agglomerans Category A 99
(3) NR37 Mycobacterium tuberculosis Category B 100
Group 4. Reference group
(1) NR51 Mycobacterium parascrofulaceum Category B 97
(2) NR52 Mycobacterium parascrofulaceum Category B 99
(3) NR53 Mycobacterium parascrofulaceum Category B 99
(4) NR54 Mycobacterium parascrofulaceum Category B 99
Table 3: Antibiogram results for microbial.
Antibiotic NR5 NR9 N17 NR24 NR43 NR31
Amikacin (AK) R I R S S R
A m p i c i l l i n ( A M )SRRRR R
C a r b e n i c i l l i n ( C B ) RRRRR R
Cefotaxima (CTX) S R R I R R
Ceftriaxone (CRO) R R R I R R
Choramphenicol
(CL) RIIRR I
Gentamycin (GE) R I I R S R
N e t i l m i c i n ( N E T ) RRRRR R
N i t r o f u r a n t o i n ( N F ) IRRRR R
P e ﬂ o x a c i n ( P E F )RRRRR R
R: Resistant; I: Intermediate; S: Susceptible.6 The Scientiﬁc World Journal
E. cloacae sub dissolvens ATCC23373 
E. ludwigii DSM16688T
P. agglomerans WAB1925
E. sp. Dc6
NR14Nau19
E. hormaechei sub oharae EN-314T
E. hormaechei sub steigerwalti EN-562T 
NR24Nau27
NR9Nau12
NR31Cachi8
E4Nau4
NR1bNau2
NR15Nau20
P. agglomerans WAB1870
NR42Capa5
NR43Capa6
NR17Nau21
NR5Nau6
P. agglomerans DSM3493
47
73
91
91
79
80
50
N. brasiliensis
Figure 1: Phylogenetic tree based on 1367bp without gaps from 16S rRNA gene. Nocardia brasiliensis was used as the out-group of phylo-
genetic tree.
but the identiﬁed organisms were P. agglomerans, Mycobac-
terium, andPseudomonas. These microorganisms are consid-
ered opportunists and the diﬀerential diagnosis is necessary
for the proper treatment before other organs are aﬀected.
ThemostlyisolatedbacteriumwasP.agglomerans,aGram
negative bacillus with predilection for the lungs. Accord-
ingtoRodr´ ıguezandMart´ ınez(2002),nosocomialinfections
in adult patients are caused by Gram negative bacilli, mainly
enterobacteria [23], a fact that agrees with Kaye (2001) who
isolated mostly P. agglomerans, in respiratory secretions [24].
On the other hand, Dom´ ınguez et al. in 2008 reported
that the most frequently isolated Gram negative bacillus is
Pseudomonas spp. followed by Enterobacter. The low number
of lymphocytes is a factor that increases the risk of these
infections [25]. In a 2005 study by Chernilo et al., there were
14 nosocomial pneumonia and in the sputum were isolated
several infectious agents: P. aeruginosa (two specimens) and
Enterobacter in one sample [26].
In general, Mycobacterium spp. presence was discarded
in Group 1 of patients but other opportunistic bacteria were
found which in HIV positive patients can be a health risk.
In Group 2 we expected to isolate Mycobacterium spp.
since these patients had the clinical symptoms and the
bacterium was conﬁrmed, but instead, P. agglomerans and
Pseudomonas spp. were found. This might have been because
the anti-TB treatment eliminated Mycobacterium and other
types of bacteria ﬂourished in these HIV positive patients.
As to the patients in Group 3, it is interesting that their
sputum was negative for Ziehl-Neelsen but culture positive.
This result implies an epidemiologic factor. The related
persons in contact with the TB patient are acid-fast bacteria
negative and are sent home without diagnosis or treatment
but they are a focus of infection for other persons.
In the present study, we conﬁrmed bacterial identiﬁca-
tion by means of the ampliﬁed sequence of 16S rRNA gene.
Molecular biology techniques are a useful tool for the conﬁr-
mation of the isolated organism, as is the case of P. agglo-
merans, a seldom mortal microorganism frequently consid-
ered as opportunistic, since the symptoms can be confused
with those caused by Mycobacterium spp. if not correctly
identiﬁed.
By means of the API 20E and 50CH biochemical assays
practiced on P. agglomerans, its biochemical and metabolic
characteristics were determined. This result might be very
useful to complement the identiﬁcation with a phenotypic
study. The resistance and sensibility of P. agglomerans to the
most frequent antimicrobial agents for Gram negative bacte-
ria were determined.
5. Conclusions
From the 32 included patients, the following strains were
identiﬁed: ten strains of P. agglomerans were in Category A;
6 strains of Mycobacterium spp. (two M. tuberculosis and 4
M. parascrofulaceum) were in Category B; six strains of Pseu-
domonas spp. (one strain of P. koreensis,o n eP. aerogenes,a n d
4strainsofP.azelaica)werefoundinpatientsintheCategory
C.IntheCategoryDtenstrainsofnormalﬂorawereisolated.The Scientiﬁc World Journal 7
Even though, initially the aim our study was the search
and identiﬁcation of Mycobacterium spp. The most frequent-
ly identiﬁed species found was P. agglomerans (31.25%) fol-
lowed by Mycobacterium spp. (18.75%) and Pseudomonas
spp. (18.75%) and several normal ﬂora bacteria represent
31.25%.
Ourresearchconﬁrmsthepresenceofopportunistic bac-
teria such as P. agglomerans in HIV positive and other im-
munodeﬁcient patients with clinical respiratory symptoms
related to TB (Mycobacterium spp.), a situation that has to be
accounted for in the correct diagnosis and patient follow-up.
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